Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Energenesis Biomedical Co., Ltd. (6657) Financial Statements

Energenesis Biomedical Co., Ltd. Financial Overview

Energenesis Biomedical Co., Ltd.'s market cap is currently NT$2.69B. The company's EPS TTM is NT$-3.39; its P/E ratio is -8.85; Energenesis Biomedical Co., Ltd. is estimated to report earnings on November 17, 2026, and the estimated EPS forecast is NT$-0.54. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 7.67MNT$ 7.75MNT$ 7.16MNT$ 7.35MNT$ 7.49M
Gross ProfitNT$ 5.83MNT$ 5.69MNT$ 5.23MNT$ 5.17MNT$ 5.36M
Operating IncomeNT$ -275.27MNT$ -255.17MNT$ -261.84MNT$ -265.45MNT$ -119.95M
EBITDANT$ -252.70MNT$ -208.06MNT$ -238.02MNT$ -241.04MNT$ -97.05M
Net IncomeNT$ -258.40MNT$ -231.08MNT$ -260.38MNT$ -265.66MNT$ -120.24M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 838.10MNT$ 664.98MNT$ 699.20MNT$ 484.67MNT$ 725.84M
Total AssetsNT$ 948.98MNT$ 780.64MNT$ 828.57MNT$ 630.86MNT$ 885.81M
Total DebtNT$ 14.84MNT$ 10.03MNT$ 8.28MNT$ 9.54MNT$ 11.94M
Net DebtNT$ -658.26MNT$ -394.48MNT$ -238.33MNT$ -80.66MNT$ -137.43M
Total LiabilitiesNT$ 52.71MNT$ 41.30MNT$ 24.59MNT$ 28.31MNT$ 33.44M
Stockholders' EquityNT$ 896.27MNT$ 739.33MNT$ 803.98MNT$ 602.56MNT$ 852.38M
Cash Flow
Free Cash FlowNT$ -224.72MNT$ -181.47MNT$ -225.89MNT$ -239.43MNT$ -106.18M
Operating Cash FlowNT$ -222.41MNT$ -180.71MNT$ -225.05MNT$ -232.84MNT$ -97.29M
Investing Cash FlowNT$ 91.83MNT$ 193.23MNT$ -58.96MNT$ 175.42MNT$ -115.76M
Financing Cash FlowNT$ 399.34MNT$ 145.28MNT$ 440.42MNT$ -1.75MNT$ 287.98M

Currency in TWD

Energenesis Biomedical Co., Ltd. Earnings and Revenue History

-300M-150M0150M-4000 %-3000 %-2000 %-1000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Energenesis Biomedical Co., Ltd. Liabilities to Assets

0400M800M1.2B2.4 %3.6 %4.8 %6 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Energenesis Biomedical Co., Ltd. Cash Flow

-400M-200M0200M400M600M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Energenesis Biomedical Co., Ltd. Forecast EPS vs Actual EPS

-1.7-1.5-1.2-1-0.7-0.5-0.2Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >